Live Price
Live Volume
Chart Volume 0
Volume 0
5 secLarimar Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
-0.00(-0.21%)
| Open | $2.24 |
|---|---|
| Close | $2.24 |
| Low | $2.21 |
| Low Change | -0.03 (-1.34%) |
| High | $2.24 |
| High Change | +0.00 (+0.00%) |
| Range | $0.03 |
| Volume | 84.679K |
| Dollar Volume | $189.29K |
Regular Trading Hours Yesterday
-0.12(-4.89%)
| Open | $2.35 |
|---|---|
| Close | $2.24 |
| Low | $2.18 |
| Low Change | -0.17 (-7.23%) |
| High | $2.39 |
| High Change | +0.04 (+1.70%) |
| Range | $0.21 |
| Volume | 1.216M |
| Dollar Volume | $2.72M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $2.35 |
|---|---|
| Close | $2.35 |
| Low | $2.35 |
| Low Change | 0.00 (0.00%) |
| High | $2.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 750 |
| Dollar Volume | $1.76K |
Larimar Therapeutics News
4 months agoinvesting.comLarimar Therapeutics stock jumps on insider purchase
- 4 months agoinvesting.com
Why is Larimar Therapeutics stock sliding today?
- 4 months agoinvesting.com
Larimar Therapeutics stock tumbles after clinical data release
- 8 months agoinvesting.com
Larimar Therapeutics stock falls 8% on upsized $100 million offering
- 8 months agoinvesting.com
Larimar Therapeutics stock surges on FDA breakthrough status
Larimar Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Larimar Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.34 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.21 |
| 20 Day Moving Average (SMA20) | $2.54 |
| 50 Day Moving Average (SMA50) | $3.35 |
| 100 Day Moving Average (SMA100) | $3.54 |
| 200 Day Moving Average (SMA200) | $3.82 |
Larimar Therapeutics Statistics
| Average Volume (30 Days) | 1.23M |
|---|---|
| P/E Ratio (Current) | -1.61 |
| EPS (Current) | -$1.66 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$156.08M |
| Cash Ratio | 2.71 |
| Current Ratio | 4.70 |
| Quick Ratio | 4.70 |
| Debt to Equity | 0.00 |
| Enterprise Value | $184.68M |
| EV to EBITDA | -1.03 |
| EV to Sales | — |
| Price to Book | 2.18 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.04% |
| Return on Equity | -1.36% |
Larimar Therapeutics Stock Splits
There have been no stock splits for Larimar Therapeutics (LRMR).
Larimar Therapeutics Dividends
There have been no dividends for Larimar Therapeutics (LRMR).